Related content

Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer

By                    

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1707-1712

Spandidos Publications

Access to resources Recommend Favorite

Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: A retrospective cohort analysis

By Nelli Fabrizio   Natoli Guido   Moscetti Luca   Massari Annalisa   D’Auria Giuliana   Fabbri Maria A   Frittelli Patrizia   Ruggeri Enzo M  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 112-118

Maney Publishing

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite

Future Directions in the Treatment of Metastatic Breast Cancer

By Zwierzina H.   Gnant M.   Krainer M.   Wiltschke Ch.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 117-118

Springer Publishing Company

Access to resources Recommend Favorite

Consensus on Medical Treatment of Metastatic Breast Cancer

By Beslija Semir   Bonneterre Jacques   Burstein Harold J.   Gnant Michael   Goodwin Pamela   Heinemann Volker   Jassem Jacek   Köstler Wolfgang   Krainer Michael   Menard Silvie   Miles David   Petruzelka Lubos   Possinger Kurt   Schmid Peter   Stadtmauer Edward   Stockler Martin   Van Belle Simon   Vogel Charles   Wilcken Nicholas   Wiltschke Christoph   Zielinski Christoph C.   Zwierzina Heinz  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite